Sickle Cell Foundation of Ghana

The Sickle Cell Foundation of Ghana (SCFG) is a prominent non-governmental organization dedicated to improving the lives of people with sickle cell disease (SCD) through advocacy, education, and clinical support. As a primary partner to the Ministry of Health in Ghana, the foundation manages the National Newborn Screening Program for Sickle Cell Disease, which is one of the largest of its kind in Africa. SCFG plays a critical role in expanding access to essential therapies, notably through a major partnership with Novartis to provide hydroxyurea to patients across the country. The organization also focuses on training healthcare professionals and establishing specialized SCD treatment centers to standardize care. By integrating research with public health initiatives, the foundation aims to reduce the high mortality rates associated with SCD in the region.